chr12-55683888-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152637.3(TMT1B):c.574G>A(p.Glu192Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152637.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMT1B | NM_152637.3 | c.574G>A | p.Glu192Lys | missense_variant | 2/2 | ENST00000394252.4 | NP_689850.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METTL7B | ENST00000394252.4 | c.574G>A | p.Glu192Lys | missense_variant | 2/2 | 2 | NM_152637.3 | ENSP00000377796.3 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152030Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000755 AC: 19AN: 251490Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135920
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461854Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727232
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152030Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.574G>A (p.E192K) alteration is located in exon 2 (coding exon 2) of the METTL7B gene. This alteration results from a G to A substitution at nucleotide position 574, causing the glutamic acid (E) at amino acid position 192 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at